UK markets closed
NIKKEI 225
39,069.68 +282.30 (+0.73%) HANG SENG
19,636.22 +82.61 (+0.42%) CRUDE OIL
79.65 -0.41 (-0.51%) GOLD FUTURES
2,430.30 +12.90 (+0.53%) DOW
39,806.77 -196.82 (-0.49%) Bitcoin GBP
54,549.71 +2,565.80 (+4.94%)
Legend Biotech Corporation (LEGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 8.23B |
| Enterprise value | 7.26B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 23.75 |
| Price/book (mrq) | 7.07 |
| Enterprise value/revenue | 21.19 |
| Enterprise value/EBITDA | -15.34 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.12 |
| 52-week change 3 | -34.51% |
| S&P500 52-week change 3 | 26.49% |
| 52-week high 3 | 77.32 |
| 52-week low 3 | 42.08 |
| 50-day moving average 3 | 52.48 |
| 200-day moving average 3 | 60.80 |
Share statistics
| Avg vol (3-month) 3 | 1.03M |
| Avg vol (10-day) 3 | 836.96k |
| Shares outstanding 5 | 182.28M |
| Implied shares outstanding 6 | 182.29M |
| Float 8 | 159.53M |
| % held by insiders 1 | 1.32% |
| % held by institutions 1 | 49.02% |
| Shares short (30 Apr 2024) 4 | 13.28M |
| Short ratio (30 Apr 2024) 4 | 12.04 |
| Short % of float (30 Apr 2024) 4 | 14.05% |
| Short % of shares outstanding (30 Apr 2024) 4 | 7.30% |
| Shares short (prior month 28 Mar 2024) 4 | 9.99M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -135.92% |
| Operating margin (ttm) | -125.40% |
Management effectiveness
| Return on assets (ttm) | -18.25% |
| Return on equity (ttm) | -51.28% |
Income statement
| Revenue (ttm) | 342.8M |
| Revenue per share (ttm) | 1.90 |
| Quarterly revenue growth (yoy) | 158.70% |
| Gross profit (ttm) | N/A |
| EBITDA | -425.38M |
| Net income avi to common (ttm) | -465.95M |
| Diluted EPS (ttm) | -2.58 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 1.3B |
| Total cash per share (mrq) | 3.57 |
| Total debt (mrq) | 334.69M |
| Total debt/equity (mrq) | 28.75% |
| Current ratio (mrq) | 5.66 |
| Book value per share (mrq) | 6.39 |
Cash flow statement
| Operating cash flow (ttm) | -238.54M |
| Levered free cash flow (ttm) | -264.06M |
© 2024 Yahoo. All rights reserved.